Plasmodium vivax gametocyte surface protein Pvs230 (Pvs230)

Plasmodium vivax gametocyte surface protein Pvs230 is a high-molecular-weight protein expressed on the surface of gametocytes and gametes of the Plasmodium vivax parasite. It belongs to the 6-Cys (or s48/45) family of proteins, characterized by conserved domains containing six cysteine residues that form essential intramolecular disulfide bonds. The primary biological function of Pvs230 is to facilitate the fertilization process within the midgut of the Anopheles mosquito vector after a infectious blood meal, where it is involved in gamete fusion and potentially the interaction between male gametes and erythrocytes. In the context of malaria control, Pvs230 is a leading transmission-blocking vaccine (TBV) candidate. Vaccines targeting this protein aim to induce a robust antibody response in the human host; when these antibodies are ingested by a mosquito, they inhibit the parasite's sexual development, thereby preventing the formation of oocysts and breaking the cycle of transmission. Clinical development typically focuses on recombinant fragments of the protein, such as the N-terminal Domain 1 (Pvs230D1), often conjugated to carrier proteins like Pseudomonas aeruginosa Exoprotein A (EPA) to improve immunogenicity. While Pvs230 exhibits significant sequence conservation across global strains, its structural complexity and the requirement for precise disulfide bond formation present significant challenges for protein expression and vaccine manufacturing.

Other names

Pvs230Gametocyte surface protein P2306-Cys protein Pvs230P. vivax P230Sexual stage antigen P230

Induction of transmission-blocking antibodies in the human host that, upon ingestion by a mosquito during a blood meal, bind to the parasite surface and inhibit gamete fertilization and subsequent development within the mosquito midgut.